Clinical Trial Update: Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on a recombinant herpes zoster vaccine being studied to prevent cardiovascular events and dementia; the trial status is NOT_YET_RE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Dementia

Drugs mentioned

• Recombinant Herpes Zoster Vaccine

Snippet

Sponsor: Tor Biering-Sørensen | Conditions: Cardiovascular Disease, Dementia | Phase 4 | Status: NOT_YET_RECRUITING